Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.

Yasukiyo MurakamiKazumasa MatsumotoMakito MiyakeNoriyuki AmanoSoichiro ShimuraNobutaka NishimuraKouta IidaYuto MatsushitaTakashige AbeTakeshi YamadaMotohide UemuraYoshiyuki MatsuiRikiya TaokaTakahiro KojimaTakashi KobayashiNaotaka NishiyamaHiroshi KitamuraHiroyuki NishiyamaKiyohide FujimotoMasatsugu Iwamura

Published in: International journal of urology : official journal of the Japanese Urological Association (2022)

This study found that the RC group showed no significant superiority compared to the non-RC group in CSS for early relapse/refractory disease in terms of first salvage therapy.

Keyphrases

muscle invasive bladder cancer
prostate cancer
type diabetes
metabolic syndrome
adipose tissue
replacement therapy
cell therapy
bacillus subtilis